KMKCX
Price
$58.86
Change
+$0.44 (+0.75%)
Updated
Sep 20 closing price
RPTIX
Price
$109.40
Change
-$0.77 (-0.70%)
Updated
Sep 20 closing price
Ad is loading...

KMKCX vs RPTIX

Header iconKMKCX vs RPTIX Comparison
Open Charts KMKCX vs RPTIXBanner chart's image
Kinetics Market Opportunities Adv C
Price$58.86
Change+$0.44 (+0.75%)
VolumeN/A
CapitalizationN/A
T. Rowe Price Mid-Cap Growth I
Price$109.40
Change-$0.77 (-0.70%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
KMKCX vs RPTIX Comparison Chart
Loading...
VS
KMKCX vs. RPTIX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KMKCX is a StrongBuy and RPTIX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RPTIX has more cash in the bank: 31.4B vs. KMKCX (184M). RPTIX pays higher dividends than KMKCX: RPTIX (0.18) vs KMKCX (0.10). KMKCX was incepted earlier than RPTIX: KMKCX (18 years) vs RPTIX (9 years). RPTIX is a more actively managed with annual turnover of: 21.70 vs. KMKCX (5.00). KMKCX has a lower initial minimum investment than RPTIX: KMKCX (2500) vs RPTIX (500000). KMKCX annual gain was more profitable for investors over the last year : 50.90 vs. RPTIX (14.81). KMKCX return over 5 years is better than : 145.13 vs. RPTIX (15.09).
KMKCXRPTIXKMKCX / RPTIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence18 years9 years-
Gain YTD50.6919.127555%
Front LoadN/AN/A-
Min. Initial Investment25005000001%
Min. Initial Investment IRAN/AN/A-
Net Assets184M31.4B1%
Annual Yield % from dividends0.100.1855%
Returns for 1 year50.9014.81344%
Returns for 3 years59.36-13.57-437%
Returns for 5 years145.1315.09962%
Returns for 10 years244.28N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLH246.88-0.54
-0.22%
Clean Harbors
TOI0.29N/A
-0.58%
Oncology Institute (The)
CINT6.59-0.04
-0.60%
CI&T
CSTM16.22-0.54
-3.22%
Constellium SE
KTTA4.43-0.37
-7.71%
Pasithea Therapeutics Corp